Advising DENTRESSANGLE in connection with the acquisition of the medtech ACTEON from BRIDGEPOINT

De Pardieu Brocas Maffei advise the family investment holding company, DENTRESSANGLE, in connection with the acquisition of a majority stake inthe French medtech company ACTEON Group from BRIDGEPOINT DEVELOPMENT CAPITAL (BDC), the Mid-Cap business of BRIDGEPOINT.

ACTEON designs and manufactures high-technology equipment and consumables for the dental sector as well as medical equipment. ACTEON is globally renowned in the field of dental imaging and is a global leader in intraoral cameras and high-intensity ultrasound (piezosurgery), a non-invasive and non-traumatic surgical technique used notably in implantology.

ACTEON, headquartered in Mérignac, France, employs 850 people across 5 plants in Europe, saw a strong increase in its turnover over the last 3 years, rising from €119 million in 2014 to €162 million in 2017. The group generates 85% of its sales outside France, its main markets are USA, China, Spain, the Middle East and Japan.

DENTRESSANGLE will bring its entrepreneurial culture to ACTEON in order to strengthen its position as an indispensable partner for dental surgeons around the world. DENTRESSANGLE wants to accelerate the development of ACTEON through increased R&D activity, expanding its global reach and implementing an external growth strategy.